Neuro42
Signal active
Organization
Contact Information
Overview
Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.
About
Industries
Biotechnology, Medical Device
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Neuro42 headquartered in United States, North America, operates in the Biotechnology, Medical Device sector. The company focuses on Biotechnology and has secured $778.2M in funding across 40 round(s). With a team of 11-50 employees, Neuro42 is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Neuro42, raised $6.7M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$19.5M
Details
2
Neuro42 has raised a total of $19.5M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 6.5M | ||
| 2021 | Seed | 1.3M |
Investors
Neuro42 is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Philip Dolan | - | FUNDING ROUND - Philip Dolan | 6.5M |
| Neuro42 | - | FUNDING ROUND - Neuro42 | 5.0M |
| Neuro42 | - | FUNDING ROUND - Neuro42 | undefined |
| Fred Moll, M.D | - | FUNDING ROUND - Fred Moll, M.D | undefined |
Recent Activity
There is no recent news or activity for this profile.